CGTX
Cognition Therapeutics, Inc.
$1.27
Earnings Summary
Net Profits | $-4.73Mn |
Highlights
Cognition Therapeutics, Inc.’s net profit jumped 17.84% since last year same period to $-4.73Mn in the Q2 2023. On a quarterly growth basis, Cognition Therapeutics, Inc. has generated -39.78% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Cognition Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.23 |
EPS Estimate Current Year | -0.23 |
Highlights
Cognition Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.23 - a -25.14% fall from last quarter’s estimates.
Cognition Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.23.
Key Ratios
Key ratios of the Cognition Therapeutics, Inc. post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Cognition Therapeutics, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Cognition Therapeutics, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-15 | -0.23 | 0 | 100% |
2023-08-08 | -0.19 | 0 | 100% |
2023-05-04 | -0.31 | 0 | 100% |
₹0 US Stocks a/c Opening Fee